IFN gene therapy was associated with sustained local production of IFN-β that efficiently suppressed tumor growth in prostate and bladder cancer as well as melanoma, renal cell carcinoma, and colon carcinoma (54–56). The gene discussed is IFNB1; the disease is neoplasm.